ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Revolution Medicines, Inc. (RVMD)

Nasdaq · Common stock · Biological Products, (no Diagnostic Substances)

$196.87+0.31 (+0.16%)

As of Oct 21, 2:17 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow RVMD in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on RVMD and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free RVMD chart →

RVMD at a glance

Key statistics

$42.13B

Market capitalization

Previous close
$196.55
Open
$197.79
Day range
$195.71 – $203.29
Volume
1.11M
Average volume (30 sessions)
2.20M
Shares outstanding
214.34M
Earnings per share
$(8.25)
Price / book
16.2
Beta (1 year, vs SPY)
1.19

Where the price sits in its year

52-week range

84% of the range

Below the 52-week high
-12.2%
Above the 52-week low
+275.1%

Completed sessions through Oct 20, 2026

Technical snapshot

Below its 50-day average, above its 200-day

20-day average
$196.39+0.1%
50-day average
$202.45-2.9%
200-day average
$152.72+28.7%
RSI (14)50.7

Between the conventional 30 and 70 bands.

+4.3%

1 week

+2.0%

1 month

+7.4%

3 months

+146.8%

Year to date

+263.3%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with RVMD

From the public news wire

RVMD headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →
  • Sandler Alan B.

    −6.0K

    Chief Development Officer · Option exercise

    · Sep 29, 2026

  • Sandler Alan B.

    −301

    Chief Development Officer · Open-market sale

    $61.62K · Sep 29, 2026

  • Sandler Alan B.

    −2.2K

    Chief Development Officer · Open-market sale

    $441.80K · Sep 29, 2026

  • Sandler Alan B.

    −1.0K

    Chief Development Officer · Open-market sale

    $202.81K · Sep 29, 2026

  • Sandler Alan B.

    +6.0K

    Chief Development Officer · Option exercise

    $353.04K · Sep 29, 2026

  • Sandler Alan B.

    −1.6K

    Chief Development Officer · Open-market sale

    $324.57K · Sep 29, 2026

  • Sandler Alan B.

    −1.2K

    Chief Development Officer · Open-market sale

    $244.48K · Sep 29, 2026

  • Cislini Jeff

    −765

    SVP & General Counsel · Open-market sale

    $158.60K · Sep 25, 2026

About Revolution Medicines, Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Exchange
Nasdaq
Security
Common stock
Industry
Biological Products, (no Diagnostic Substances)
Headquarters
Redwood City, CA
Employees
883
Listed since
Feb 13, 2020
Website
revmed.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.